CG Oncology, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CGON Nasdaq 2836 cgoncology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CG Oncology, Inc.

CG Oncology to Present at Upcoming Investor Conferences in June - May 28th, 2026 2:05 pm
Sector Update: Healthcare Stocks Decline Late Afternoon - May 26th, 2026 1:54 pm
Sector Update: Healthcare Stocks Decline Tuesday Afternoon - May 26th, 2026 11:50 am
CG Oncology Touts Bladder Cancer Data, Q4 Filing Plans at RBC Conference - May 20th, 2026 8:04 pm
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - May 19th, 2026 6:00 am
Assessing CG Oncology (CGON) Valuation After Positive Phase 2 CORE-008 Bladder Cancer Data - May 17th, 2026 8:11 am
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients - May 15th, 2026 6:00 am
CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears - May 15th, 2026 1:07 am
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC - May 11th, 2026 2:15 pm
RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst - May 10th, 2026 5:14 pm
What CG Oncology (CGON)'s Bigger Loss and Cash Runway Through 2029 Means For Shareholders - May 10th, 2026 12:06 am
CG Oncology, Inc. (CGON) Reports Q1 Loss, Tops Revenue Estimates - May 8th, 2026 7:35 am
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates - May 8th, 2026 6:30 am
Gilead Sciences (GILD) Tops Q1 Earnings and Revenue Estimates - May 7th, 2026 3:15 pm
Wall Street Analysts Think CG Oncology, Inc. (CGON) Could Surge 29.78%: Read This Before Placing a Bet - May 5th, 2026 7:55 am
CG Oncology to Present at Upcoming Investor Conferences in May - May 5th, 2026 6:00 am
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - May 4th, 2026 7:40 am
CG Oncology, Inc. (CGON) Upgraded to Buy: Here's What You Should Know - May 1st, 2026 10:00 am
Is CG Oncology’s New CFO Hire (CGON) Reframing Its Oncolytic Immunotherapy Investment Story? - Apr 23rd, 2026 10:29 pm
CG Oncology (CGON) Rallied on Pivotal Clinical Results - Apr 21st, 2026 8:33 am